BioLineRx Initiates Phase 2 Trial of a Stem Cell Mobilization Agent for Lymphoma Treatment – Lymphoma News Today
Lymphoma News Today |
BioLineRx Initiates Phase 2 Trial of a Stem Cell Mobilization Agent for Lymphoma Treatment
Lymphoma News Today BioLineRx, Ltd., has announced the initiation of a Phase 2 trial of BL-8040 as a single agent to mobilize and collect bone marrow stem cells from peripheral blood circulation, which will be used to harvest hematopoietic stem cells to treat several … |
